Harvest Volatility Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,453
Closed -$2.96M 57
2023
Q2
$2.96M Sell
38,453
-6,376
-14% -$509K 0.59% 30
2023
Q1
$3.65M Sell
44,829
-8,078
-15% -$669K 0.74% 26
2022
Q4
$4.54M Sell
52,907
-13,542
-20% -$1.07M 0.92% 24
2022
Q3
$4.11M Sell
66,449
-1,471
-2% -$92.8K 0.71% 28
2022
Q2
$4.2M Sell
67,920
-8,355
-11% -$517K 0.68% 30
2022
Q1
$4.54M Buy
76,275
+76,198
+98,958% +$4.87M 0.51% 36
2021
Q4
$5.56K Sell
77
-57,782
-100% -$3.98M ﹤0.01% 50
2021
Q3
$4.04M Buy
57,859
+21,814
+61% +$1.53M 0.19% 38
2021
Q2
$2.48M Buy
36,045
+8,750
+32% +$584K 0.2% 44
2021
Q1
$1.76M Buy
27,295
+10,468
+62% +$675K 0.16% 42
2020
Q4
$980K Buy
+16,827
New +$1.02M 0.11% 50

Other funds holding GILD

Harvest Volatility Management's GILD Position: Q3 2023 in Review

Harvest Volatility Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 38,453 shares — an estimated $2.96M sold.

Harvest Volatility Management first reported a position in GILD in Q4 2020 and held it in 11 quarters. The position peaked at $4.54M in Q4 2022. 1,683 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Harvest Volatility Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 38,453 Gilead Sciences shares in Q3 2023, an estimated $2.96M.
  • Harvest Volatility Management first reported a position in Gilead Sciences in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's Gilead Sciences position peaked at $4.54M in Q4 2022.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.